3-(3-(Dimethoxymethyl)-1H-pyrazol-5-yl)pyridine

Catalog No.: 
ACZKRD026
CAS No.: 
1680191-51-8
Molecular Formula: 
C11H13N3O2
Molecular Weight: 
219.24
3-(3-(Dimethoxymethyl)-1H-pyrazol-5-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$52.00In stockInquiry
1g97%$138.00In stockInquiry
5g97%$486.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-(Dimethoxymethyl)-1H-pyrazol-5-yl)pyridine
IUPAC Name3-(3-(dimethoxymethyl)-1H-pyrazol-5-yl)pyridine
Molecular FormulaC11H13N3O2
Molecular Weight219.24
SMILESCOC(C1=NNC(C2=CC=CN=C2)=C1)OC
InChI KeyNGQYFGBTGPYTGO-UHFFFAOYSA-N
SynonymPyridine, 3-[5-(dimethoxymethyl)-1H-pyrazol-3-yl]-;3-(3-(Dimethoxymethyl)-1H-pyrazol-5-yl)pyridine
CAS No.1680191-51-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZKRD026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGADK973 route compound structure diagram
    ACGADK973329214-79-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZKRD026 route product structure diagram
    ACZKRD0261680191-51-8In Stock
Inquiry

2. ACZKRD026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZKRD026 route product structure diagram
    ACZKRD0261680191-51-8In Stock
Inquiry

3. ACZKRD026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZKRD026 route product structure diagram
    ACZKRD0261680191-51-8In Stock
Inquiry

Comments (0)